Supplement industry news and updates – April 2024

Both CRN and NPA challenge New York dietary supplement law – article

Both the Council for Responsible Nutrition and the Natural Products Association filed separate suits against a new New York law restricting minors’ access to certain OTC diet pills or supplements marketed for muscle building or weight loss. Find out why and what potential impact this law could have on the industry beyond New York here.

Product intelligence supplement attribute spotlight, SPINS intelligence: Prebiotic fibers  analysis

Gut health has been a rising consumer trend for years and prebiotic fibers (or just prebiotics) have been a rising star in products related to this movement for nearly a decade! That said, consumer questions remain that industry needs to address: What are prebiotics? Are they fibers? Are they also probiotic? Read on about how these concepts are trending and learn why you should expect to continue seeing strong prebiotics demand here.

FDA releases new NDI master file draft guidance – article

Learn how master files can be used to facilitate the submission of information to FDA for evaluating potential NDI (new dietary ingredient) notifications. Steve Mister, president and CEO of the Council for Responsible Nutrition, described FDA's new draft guidance on the files as a "positive development.” Consumer Healthcare Products Association’s SVP of Dietary Supplements Duffy MacKay said a solid system could encourage companies to increase safety research investment. Read more here.

Prevagen jury trial: After 7 years, Quincy Bioscience wins and loses – article

The company behind Prevagen, marketed to improve memory (with over $165 million in U.S. sales), has been battling the New York attorney general and the Federal Trade Commission for seven years over possible deceptive business practices and false advertising. Find out why the recently returned jury verdict failed to score a knock-out punch for either side here.

Expo West reveals hot trends for supplement innovators – article

Among the 600 supplement industry exhibitors presenting their products at Natural Products Expo West, four trends emerged primed to move the market in 2024. Ozempic and other GLP-1 drugs’ multifaceted effect on ingredients and products supporting healthy metabolism, gut health and the microbiome was one. Find out what you need to know about it and the other three market-shaping supplement storylines here.

5 key takeaways from new FDA NDI guidance – article

The Food and Drug Administration recently published a guidance document on a notification requirement in DSHEA that may be more important than ever. Find out what you need to know from the 16-page guide and learn why all those pages on NDIs may be for nothing unless FDA holds firms accountable for circumventing the notification requirement here.